Loading...

BIOLASE, Inc.

BIOL•NASDAQ
Healthcare
Medical - Devices
$0.02
$0.004(27.39%)

BIOLASE, Inc. (BIOL) Stock Overview

Explore BIOLASE, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 64.2/100

Key Financials

Market Cap731.9K
P/E Ratio-0.07
EPS (TTM)$16.18
ROE2.80%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.30

BIOL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BIOLASE, Inc. (BIOL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.07 and a market capitalization of 731.9K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;